Effectiveness and rapidity on olfatory fuction recovery in CRS patients treated with Dupilumab: a real life prospective controlled study.

Ignazio La MantiaEgle GrigaliuteMartina RagusaSalvatore CocuzzaThomas RadulescoAlberto Maria SaibeneChristian Calvo-HenriquezNicolas FakhryJustin MichelAntonino Maniaci

Published in: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2023)

Patients who receive dupilumab treatment may experience a faster recovery of olfactory function compared to those receiving corticosteroid therapy. This result would be maintained regardless of the severity of type 2 CRSwNP inflammation, the volume of the polyps, or the patient's subjective symptomatology.

Keyphrases

atopic dermatitis
oxidative stress
randomized controlled trial
systematic review
case report
sleep quality
combination therapy
chronic rhinosinusitis
cell therapy